Value of PET /CT and diagnostic CT scan in differentiated thyroid carcinoma patients with high serum thyroglobulin and negative 131I whole body scan

Dr Bui Quang Bieu1, Dr Le Ngoc Ha1
1 Faculty of Nuclear Medicine, Diseases Military Central Institute 108

Main Article Content

Abstract

Objective: to determine value of FDG-PET/CT and diagnostic CT scan in post-surgical differentiated thyroid carcinoma patients
with high serum thyroglobulin and negative 131I whole body scan.


Patients and method: We performed FDG-PET/CT and diagnostic CT scan in 49 post-surgical differentiated thyroid carcinoma patients with high serum thyroglobulin and negative 131I whole body scan who already underwent 131I therapy in Department
of Nuclear Medicine, 108 Central Military Hospital.
Results: 41 lesions detected in 29/49 patients (59.2%) with positive PET/CT scan compared to only 20 lesions 18/49 patients
(36.7%) detected on positive CT scan. The Sn, Ac and NPV of FDG-PET/CT were 83.9%, 83.7% and 75% higher than those of CT
(51.6%, 65.3% and 51.6%, respectively). Sp and PPV of FDG-PET/ CT (83.3% and 89.7%, respectively) were similar to those of CT
(88.9%). SUVmax thresholds with good diagnostic value were 4.5 (Sn 84.6%, Sp 66.7%) and 5.0 ( Sn 65.3%, Sp 100%). FDG-PET/CT
had altered treatment plan in 25/49 patients (51.2%).
Conclusion: FDG-PET/CT is superior than CT in detecting reccurent/metastatic lesions in post-surgical differentiated thyroid
carcinoma patients with high serum thyroglobulin and negative 131I whole body scan.

Article Details

References

1. Lê Ngọc Hà và cs (2010), Nghiên cứu đặc điểm hình ảnh 18F-FDG PET/CT ở BN UT tuyến giáp biệt hóa có nồng độ thyroglobulin huyết thanh cao và xạ hình toàn thân 131I âm tính, Tạp chí Y dược lâm sàng 108, tập 6, tr 46-53.
2. Lê Duy Hưng và cs (2009), Nghiên cứu một số đặc điểm lâm sàng và đánh giá kết quả điều trị bằng 131I ở BN di căn do UT tuyến giáp thể biệt hóa sau phẫu thuật, Tạp chí Y dược lâm sàng 108, tập 4, tr 93-99.
3. Altenvoerde G et al (1998), Positron emission tomography with F-18-deoxy glucose in patients with differentiated thyroid carcinoma, elevated thyroglobin levels, and negative iodine scans, Langenbecks Arch Surg, 383, pp 160-3.
4. Atkins FB, Van Nostrand D (2006), Radioiodine Whole Body Imaging, Thyroid Cancer a comprehensive guide to clinical management, Second edition, Humana Press, pp 133-50.
5. Baudin E et al (2003), Positive predictive value of serum thyroglobulin levels, mesured during the first year of follow-up after thyroid hormon withdrawal, in thyroid cancer patients, J Clin Endocrinol Metab, 88, pp 1107-11.
6. Chung JK et al (1999), Value of FDG PET in papillary thyroid carcinoma with negative 131I Whole-Bogy Scan, J Nucl Med, 40, pp 986-92.
7. David SC et al (2009), Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid, 19(11), pp 1167-214.